EU in Advanced Talks With Johnson & Johnson on Covid-19 Vaccine Deal

Kamis, 18 Juni 2020 | 17:47 WIB
EU in Advanced Talks With Johnson & Johnson on Covid-19 Vaccine Deal
[ILUSTRASI. Small bottles labeled with a 'Vaccine COVID-19' sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration]
Reporter: Sumber: Reuters | Editor: Narita Indrastiti

KONTAN.CO.ID - BRUSSELS (Reuters). The European Commission is in advanced talks with pharmaceutical giant Johnson & Johnson to reserve or buy up-front doses of its COVID-19 vaccine under development, two officials familiar with the talks told Reuters.

The move would be the first arranged by the European Union executive since it was mandated last week by the 27 EU national governments to use an emergency fund with more than 2 billion euros ($2.3 billion) available to reach advance purchase or call-option deals with up to six vaccine makers.

The Commission’s deal with the U.S. firm Johnson & Johnson is “in the pipeline”, a top health official from an EU member state said, asking to remain anonymous as was mentioning confidential discussions about vaccines between the EU executive and EU governments.

A second EU source said the Commission had a call with Johnson & Johnson on Tuesday over the possible agreement on its potential vaccine.

A Commission spokesman had no comment. Johnson & Johnson was not immediately available for comment outside U.S. business hours.

It was unclear whether any deal would involve an advance purchase of the vaccine in testing, or an option to buy it.

Johnson & Johnson plans next month to start human clinical trials for its experimental vaccine against the highly contagious coronavirus, which has infected more than 8.36 million people worldwide, with 447,985 deaths.

Germany, France, Italy and the Netherlands said last week they had acquired 400 million potential vaccine doses, in principle available to all member states, from British drugmaker AstraZeneca, which is developing a COVID-19 shot in conjunction with Oxford University.

AstraZeneca signed a similar deal in May with the United States.

The health official from an EU state said the EU deal with Johnson & Johnson could be announced as early as next week, but cautioned that it might take a little longer to finalise, and there were still chances it might not be struck at all.

EU decision-making procedures pose a sticking point for the potential deal, with member states still in talks over the establishment of a steering board for vaccine negotiations with drugmakers, officials told Reuters.

They said that under a draft plan devised by the EU Commission, which is still to be approved by EU governments, a green light from just four member states would be enough to start formal EU talks with a drugmaker.

But, underlining the urgency of securing a vaccine for the EU’s 450 million population, the Commission had already begun talks with Johnson & Johnson even before the steering board has been agreed.

By buying vaccines under development, the EU risks acquiring shots that may eventually prove unsuccessful against COVID-19.

But the risk is justified by the need to secure enough doses for the EU population in the global race for an effective vaccine, EU officials say.

Bagikan

Berita Terbaru

Beleid Co-Payment Siap Rilis Lagi, Besarnya 5% dan Ganti Nama Jadi Re-Sharing
| Kamis, 18 September 2025 | 15:30 WIB

Beleid Co-Payment Siap Rilis Lagi, Besarnya 5% dan Ganti Nama Jadi Re-Sharing

Perusahaan asuransi wajib menyediakan produk tanpa fitur pembagian risiko, tapi juga diperbolehkan menawarkan produk dengan skema re-sharing.

Pemerintah Mengubah Postur Anggaran, Defisit Kian Lebar dan Transfer ke Daerah Naik
| Kamis, 18 September 2025 | 15:19 WIB

Pemerintah Mengubah Postur Anggaran, Defisit Kian Lebar dan Transfer ke Daerah Naik

Banggar DPR RI bersama pemerintah telah menyetujui perubahan postur RAPBN 2026. Pendapatan, belanja, dan defisit disesuaikan.

Harga Saham BBRI Kembali ke Jalur Menanjak Seiring Akumulasi Blackrock dan JP Morgan
| Kamis, 18 September 2025 | 08:38 WIB

Harga Saham BBRI Kembali ke Jalur Menanjak Seiring Akumulasi Blackrock dan JP Morgan

Pertumbuhan kredit Bank BRI (BBRI) diproyeksikan lebih bertumpu ke segmen konsumer dan korporasi, khususnya di sektor pertanian dan perdagangan. 

Investor Asing Pandang Netral ke Perbankan Indonesia, BBCA, BMRI, & BBRI Jadi Jagoan
| Kamis, 18 September 2025 | 07:55 WIB

Investor Asing Pandang Netral ke Perbankan Indonesia, BBCA, BMRI, & BBRI Jadi Jagoan

Likuiditas simpanan dan penyaluran kredit perbankan yang berpotensi lebih rendah sepanjang tahun ini jadi catatan investor asing.

Menanti Tuah Stimulus Saat Ekonomi Masih Lemah
| Kamis, 18 September 2025 | 07:19 WIB

Menanti Tuah Stimulus Saat Ekonomi Masih Lemah

Meski berisiko, penempatan dana ini bisa jadi sentimen positif bagi saham perbankan, karena ada potensi perbaikan likuiditas dan kualitas aset.

JITEX Bidik Transaksi Rp 14,9 Triliun
| Kamis, 18 September 2025 | 07:15 WIB

JITEX Bidik Transaksi Rp 14,9 Triliun

JITEX 2025 diikuti  335 eksibitor dan 258 buyer. Tahun ini kami menghadirkan buyer internasional dari sembilan negara dan lebih banyak investor

 Pengusaha Minta Setop Impor Baki Makan Bergizi
| Kamis, 18 September 2025 | 07:12 WIB

Pengusaha Minta Setop Impor Baki Makan Bergizi

Kapasitas produksi dalam negeri dinilai mampu memenuhi kebutuhan food tray program MBG. sehingga tidak perlu impor

Progres Proyek LRT  Fase 1B Capai 69,88%
| Kamis, 18 September 2025 | 07:00 WIB

Progres Proyek LRT Fase 1B Capai 69,88%

Pada Zona 1, yakni Jl. Pemuda Rawamangun dan Jl. Pramuka Raya, progres pembangunan telah mencapai 69,06%

Penjualan Ciputra (CTRA) Bisa Terpacu Tren Bunga Layu
| Kamis, 18 September 2025 | 06:58 WIB

Penjualan Ciputra (CTRA) Bisa Terpacu Tren Bunga Layu

CTRA berada di posisi yang tepat untuk mempertahankan pertumbuhan, margin, dan mendorong nilai jangka panjang

Permintaan Tumbuh, BSDE Rajin Merilis Ruko Baru
| Kamis, 18 September 2025 | 06:57 WIB

Permintaan Tumbuh, BSDE Rajin Merilis Ruko Baru

BSDE mengantongi marketing sales ruko Rp 1,26 triliun atau berkontribusi sekitar 25% dari total pra-penjualan di semester I-2025

INDEKS BERITA

Terpopuler